Anti-rabies monoclonal antibody - Serum Institute of India/MassBiologics

Drug Profile

Anti-rabies monoclonal antibody - Serum Institute of India/MassBiologics

Alternative Names: RAB-1; Rabies human monoclonal antibody - Serum Institute of India; Rabishield; RMab; SII RMab

Latest Information Update: 04 Oct 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Centers for Disease Control and Prevention; MassBiologics; University of Massachusetts Medical School
  • Developer Serum Institute of India
  • Class Antivirals; Monoclonal antibodies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Rabies

Most Recent Events

  • 04 Oct 2016 Launched for Rabies in India (IM) before October 2016(Serum Institute of India, October 2016)
  • 06 Sep 2013 Isconova is now called Novavax AB
  • 22 Aug 2013 Isconova has been acquired by Novavax
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top